Epidemiology and natural history of hepatitis C virus infection
about
Living donor liver transplantation in Taiwan-challenges beyond surgeryMicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinomaHepatitis B virus and hepatitis C virus infection in healthcare workersNatural killer cells in hepatitis C: Current progressUpdate on hepatitis B and C virus diagnosisEconomic evaluation of screening programs for hepatitis C virus infection: evidence from literatureEpidemiology of hepatitis C in GreeceEnhancing our understanding of current therapies for hepatitis C virus (HCV)Infections in Cancer Patients with Solid Tumors: A Review.Diagnostic accuracy of point-of-care tests for hepatitis C virus infection: a systematic review and meta-analysisA major shift of viral and nutritional risk factors affects the hepatocellular carcinoma risk among Ivorian patients: a preliminary report.HIV and HCV Medications in End-Stage Renal Disease.Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.Genetic variation in the microsomal triglyceride transfer protein (-493G/T) is associated with hepatic steatosis in patients infected with hepatitis C virusPerformance of the New Aptima HCV Quant Dx Assay in Comparison to the Cobas TaqMan HCV2 Test for Use with the High Pure System in Detection and Quantification of Hepatitis C Virus RNA in Plasma or SerumFinancial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives.Toll-Like Receptor 3 is Associated With the Risk of HCV Infection and HBV-Related Diseases.Tumour virus epidemiology.Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin for Treatment of Hepatitis C Virus Genotype 1: A Systematic Review and Meta-analysis.Interaction effects among IFN-γ+874, IL-2-330, IL-10-1082, IL-10-592 and IL-4-589 polymorphisms on the clinical progression of subjects infected with hepatitis B virus and/or hepatitis C virus: a retrospective nested case-control study.The dollars and sense of chronic hepatitis C infection managementClinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C.Three variants in the nicotinamide adenine dinucleotide phosphate oxidase complex are associated with HCV-related liver damage.Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption.Seroprevalence and risk factors of hepatitis B and C virus infections in female workers of Lao garment factoriesAn Efficient Chemoenzymatic Process for Preparation of Ribavirin
P2860
Q26749769-51C5993E-E314-4381-8F48-4A8CCDB7FC20Q26751392-7F924A79-628B-4285-B3A5-FF6954F63D79Q26765801-E30932D0-CEBD-43F7-8CEF-DF5CCABFA596Q26773264-0D72B173-CBBF-4B66-A20E-D52CF6F756CCQ26777048-7264866F-6128-4AC5-A0E7-FB6C560FEE70Q26998567-2E27CFEC-7A7A-476A-AB4E-3D0AD54DF722Q28074447-7B7F54FE-AC47-425D-AFDB-3DF2921DDE82Q28085718-6BC29CA1-DC47-40C8-96CF-84D0A73B41F6Q30238576-637FDBDB-6C68-4726-8D12-A164B0FD499BQ35224772-68CE3C3F-50D1-4907-91B4-ADA089D7858FQ35800572-F29C917B-74FD-4E10-8BC2-1C5B93F80825Q35832564-9E8A3405-127B-4757-9514-99B435C7B5D2Q35942087-F27C9F9B-2007-47EE-BBE5-06D7BF2016CFQ36168072-C3968C34-AA75-4779-928A-D7871A06A007Q36258800-A43D74AB-FC09-471B-879E-F1FAFE1787EDQ36327172-722DCCBC-1F1B-4AC1-A6C9-14DDAE1448F8Q36734896-E14FA861-BD99-4FD0-B67B-A3366793F232Q37170571-1B8D0D93-E550-4E57-B231-1D48E2532A6DQ38844862-FA56D415-D83A-4268-945C-FC32174C453AQ40046664-6F933F36-6573-4A1A-984D-AEAD01A5465DQ40058097-05E96685-1B9F-4A95-9F2D-341ED2E49802Q40071379-3D883611-B535-455C-BF8E-CDDA7DBEFA9FQ41075768-1D2441B3-B94E-4490-B82E-25F66A3A2EB5Q47108259-E57FF14C-F04A-4011-B00A-B720F30EC950Q52384628-8EB1A6D8-D068-45E8-914A-3E73B9DC5106Q52658108-B22AE95A-1212-4CAF-ABC8-66F89859F51AQ56977212-DB1155E8-BB58-4163-9BE6-D54FE63F99B3Q59107311-A398DECC-FEC7-4EBB-BED7-FE9E0403E0B9
P2860
Epidemiology and natural history of hepatitis C virus infection
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Epidemiology and natural history of hepatitis C virus infection
@ast
Epidemiology and natural history of hepatitis C virus infection
@en
type
label
Epidemiology and natural history of hepatitis C virus infection
@ast
Epidemiology and natural history of hepatitis C virus infection
@en
prefLabel
Epidemiology and natural history of hepatitis C virus infection
@ast
Epidemiology and natural history of hepatitis C virus infection
@en
P2093
P2860
P356
P1476
Epidemiology and natural history of hepatitis C virus infection
@en
P2093
Chien-Jen Chen
Gilbert L'Italien
Hwai-I Yang
Mei-Hsuan Lee
P2860
P304
P356
10.3748/WJG.V20.I28.9270
P407
P577
2014-07-01T00:00:00Z